Evaluation of Two Therapies for the Treatment of Osteoarticular Inflammation in Dyspeptic Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

490

Participants

Timeline

Start Date

February 17, 2016

Primary Completion Date

October 28, 2016

Study Completion Date

March 17, 2017

Conditions
Acute and Chronic InflammationDyspepsia
Interventions
DRUG

Nimesulide + Pantoprazole

1 tablet each 12 hours for 14 days plus 1 tablet each 12 hours for 14 days of the Naproxen + Esomeprazole placebo.

DRUG

Naproxen + Esomeprazole

1 tablet each 12 hours for 14 days plus 1 tablet each 12 hours for 14 days of the Nimesulide + Pantoprazole placebo.

Trial Locations (1)

13.084-791

Allegisa, Campinas

Sponsors

Lead Sponsor

All Listed Sponsors
lead

EMS

INDUSTRY

NCT01670552 - Evaluation of Two Therapies for the Treatment of Osteoarticular Inflammation in Dyspeptic Patients | Biotech Hunter | Biotech Hunter